Medicxi Growth I LP 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-31 4:00 pm Purchase | 2022-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | Medicxi Growth I LP | 19,963,157 21.100% | 1,839,265 (+10.15%) | Filing |
| 2022-02-08 08:27 am Purchase | 2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | Medicxi Growth I LP | 18,123,892 20.160% | 18,123,892 (New Position) | Filing |